Anixa Biosciences, Inc. (ANIX)
NASDAQ: ANIX · Real-Time Price · USD
2.900
-0.010 (-0.34%)
Oct 9, 2026, 4:00 PM EDT - Market closed
Anixa Biosciences Market Cap
Anixa Biosciences has a market cap or net worth of $100.82 million as of October 9, 2026. It is the 25,372nd most valuable company in the world and the 4,118th biggest in the United States. Its market cap has decreased by 31.04% in one year.
Market Cap
100.82M
Enterprise Value
87.13M
1-Year Change
-31.04%
Global Rank
Country Rank
#4,118 United States
Category
ChartMarket Cap Chart
Since December 1, 1998, Anixa Biosciences's market cap has increased from $83.20M to $100.82M, an increase of 21.17%. That is a compound annual growth rate of 0.69%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2026 | 100.82M | -1.84% |
| Dec 31, 2025 | 102.70M | 37.48% |
| Dec 31, 2024 | 74.70M | -38.06% |
| Dec 29, 2023 | 120.60M | -7.44% |
| Dec 30, 2022 | 130.30M | 46.40% |
| Dec 31, 2021 | 89.00M | 21.92% |
| Dec 31, 2020 | 73.00M | 10.11% |
| Dec 31, 2019 | 66.30M | -10.04% |
| Dec 31, 2018 | 73.70M | 106.44% |
| Dec 29, 2017 | 35.70M | -24.52% |
| Dec 30, 2016 | 47.30M | 79.85% |
| Dec 31, 2015 | 26.30M | 10.04% |
| Dec 31, 2014 | 23.90M | -39.34% |
| Dec 31, 2013 | 39.40M | 18.32% |
| Dec 31, 2012 | 33.30M | 73.44% |
| Dec 30, 2011 | 19.20M | -39.81% |
| Dec 31, 2010 | 31.90M | -65.14% |
| Dec 31, 2009 | 91.50M | 61.95% |
| Dec 31, 2008 | 56.50M | -63.00% |
| Dec 31, 2007 | 152.70M | 62.27% |
| Dec 29, 2006 | 94.10M | 31.24% |
| Dec 30, 2005 | 71.70M | -0.42% |
| Dec 31, 2004 | 72.00M | 94.07% |
| Dec 31, 2003 | 37.10M | 183.21% |
| Dec 31, 2002 | 13.10M | -52.88% |
View and export this data all the way back to 1998. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Vivani Medical | 110.05M |
| Tenax Therapeutics | 104.54M |
| Black Diamond Therapeutics | 103.70M |
| Biomea Fusion | 103.65M |
| Aardvark Therapeutics | 102.42M |
| Milestone Pharmaceuticals | 102.16M |
| Corbus Pharmaceuticals Holdings | 101.83M |
| PolyPid | 101.36M |